In yesterday’s Wall Street session, Danaher Corp. (NYSE:DHR) shares traded at $250.41, down -1.07% from the previous session.
DHR stock price is now 0.68% away from the 50-day moving average and 9.74% away from the 200-day moving average. The market capitalization of the company currently stands at $185.44B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $280, HSBC Securities recently Upgraded its rating from Hold to Buy for Danaher Corp. (NYSE: DHR). On January 24, 2024, Barclays Downgraded its previous ‘Overweight’ rating to ‘Equal Weight’ on the stock keeping its target price maintained at $240, while ‘HSBC Securities’ rates the stock as ‘Hold’
In other news, Raskas Daniel, SVP – Corporate Development sold 23,757 shares of the company’s stock on Feb 26 ’24. The stock was sold for $5,986,764 at an average price of $252.00. Upon completion of the transaction, the SVP – Corporate Development now directly owns 38,102 shares in the company, valued at $9.54 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 15 ’24, Director LOHR WALTER G sold 3,289 shares of the business’s stock. A total of $826,032 was realized by selling the stock at an average price of $251.15. This leaves the insider owning 14,129 shares of the company worth $3.54 million. A total of 8.82% of the company’s stock is owned by insiders.
During the past 12 months, Danaher Corp. has had a low of $182.09 and a high of $259.00. As of last week, the company has a debt-to-equity ratio of 0.36, a current ratio of 1.85, and a quick ratio of 1.51.
According to the Diagnostics & Research Company, earnings per share came in at 2.05, beating analysts’ expectations of 2.01 by 0.04. This compares to $0.28 EPS in the same period last year. The net profit margin was 16.78% and return on equity was 8.47% for DHR. The company reported revenue of $5.8 billion for the quarter, compared to $5.95 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.57 percent. For the current quarter, analysts expect DHR to generate $5.66B in revenue.
